INOVSYNTH

Innovassynth Technologies (India) Ltd., incorporated in 2008, operates as a research-driven Contract Research Development and Manufacturing Organization (CRDMO) in the specialty chemicals and life sciences industries. The company focuses on the development and manufacturing of complex chemical molecules, with a global presence, particularly manufacturing protected nucleosides and modified phosphoramidites used in clinical and therapeutic oligonucleotide applications. It has a strategic relationship with its parent investment entity, Innovassynth Investments Ltd, a holding and investment company. In late 2024, Innovassynth Technologies underwent a strategic merger with Innovassynth Investments Ltd to consolidate operations, aiming to enhance business synergies and resource utilization.